Niranjan Bhat

5.1k total citations · 1 hit paper
55 papers, 2.2k citations indexed

About

Niranjan Bhat is a scholar working on Epidemiology, Infectious Diseases and Microbiology. According to data from OpenAlex, Niranjan Bhat has authored 55 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Epidemiology, 15 papers in Infectious Diseases and 8 papers in Microbiology. Recurrent topics in Niranjan Bhat's work include Influenza Virus Research Studies (20 papers), Respiratory viral infections research (20 papers) and Pneumonia and Respiratory Infections (19 papers). Niranjan Bhat is often cited by papers focused on Influenza Virus Research Studies (20 papers), Respiratory viral infections research (20 papers) and Pneumonia and Respiratory Infections (19 papers). Niranjan Bhat collaborates with scholars based in United States, Switzerland and Canada. Niranjan Bhat's co-authors include Ruth A. Karron, David R. Murdoch, Katherine L. O’Brien, Amanda J. Driscoll, Christian Yoder, Judith Falloon, Michael A. Polis, Henry Masur, Richard T. Davey and Julia A. Metcalf and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Gastroenterology and PLoS ONE.

In The Last Decade

Niranjan Bhat

52 papers receiving 2.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

HIV-1 and T cell dynamics after interruption of highly active antiretroviral therapy (HAART) in patients with a history of sustained viral suppression

1999 639 citations Niranjan Bhat et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Niranjan Bhat United States	22	1.1k	773	632	340	203	55	2.2k
Tessa Goetghebuer Belgium	24	819 0.8×	748 1.0×	259 0.4×	683 2.0×	102 0.5×	53	2.0k
Karina Butler Ireland	29	975 0.9×	1.4k 1.8×	657 1.0×	187 0.6×	69 0.3×	108	2.6k
F. Lucht France	23	674 0.6×	950 1.2×	317 0.5×	211 0.6×	107 0.5×	124	2.1k
Michael L. Tapper United States	20	1.6k 1.5×	702 0.9×	320 0.5×	218 0.6×	135 0.7×	33	2.4k
Szu‐Min Hsieh Taiwan	27	1.3k 1.2×	1.5k 1.9×	377 0.6×	254 0.7×	71 0.3×	162	2.6k
Laurence Baril France	28	687 0.6×	1.0k 1.3×	254 0.4×	209 0.6×	137 0.7×	74	2.5k
Anja Poulsen Denmark	27	989 0.9×	1.0k 1.3×	490 0.8×	1.1k 3.2×	648 3.2×	115	2.8k
Wayne Greaves United States	24	1.2k 1.1×	1.2k 1.6×	826 1.3×	226 0.7×	50 0.2×	62	2.4k
Marina Giuliano Italy	28	1.2k 1.1×	1.2k 1.6×	518 0.8×	181 0.5×	63 0.3×	103	2.4k
Alejandra Gurtman United States	28	1.9k 1.8×	772 1.0×	105 0.2×	189 0.6×	124 0.6×	78	2.8k

Countries citing papers authored by Niranjan Bhat

Since Specialization

Citations

This map shows the geographic impact of Niranjan Bhat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Niranjan Bhat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Niranjan Bhat more than expected).

Fields of papers citing papers by Niranjan Bhat

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Niranjan Bhat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Niranjan Bhat. The network helps show where Niranjan Bhat may publish in the future.

Co-authorship network of co-authors of Niranjan Bhat

This figure shows the co-authorship network connecting the top 25 collaborators of Niranjan Bhat. A scholar is included among the top collaborators of Niranjan Bhat based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Niranjan Bhat. Niranjan Bhat is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Puthanakit, Thanyawee, Kulkanya Chokephaibulkit, Suvaporn Anugulruengkitt, et al.. (2025). Infant Responses to Primary Immunization Following Vaccination in Pregnancy With Varying Doses of Recombinant Acellular Pertussis Vaccine Alone or Combined With Tetanus-Diphtheria. The Pediatric Infectious Disease Journal. 44(2S). S56–S60. 3 indexed citations

Abu-Raya, Bahaa, Giuseppe Del Giudice, Anita H.J. van den Biggelaar, et al.. (2025). Avidity of pertussis toxin antibodies following vaccination with genetically versus chemically detoxified pertussis toxin-containing vaccines during pregnancy. Frontiers in Immunology. 16. 1569151–1569151. 1 indexed citations

Agbenyega, Tsiri, Anne Schuind, Samuel Adjei, et al.. (2025). Immunogenicity and safety of an Escherichia coli-produced bivalent human papillomavirus vaccine (Cecolin) in girls aged 9–14 years in Ghana and Bangladesh: a randomised, controlled, open-label, non-inferiority, phase 3 trial. The Lancet Infectious Diseases. 25(8). 861–872. 1 indexed citations

Abraham, Dilip, et al.. (2024). Effect of Non-Rotavirus Enteric Infections on Vaccine Efficacy in a ROTASIIL Clinical Trial. American Journal of Tropical Medicine and Hygiene. 110(6). 1201–1209. 2 indexed citations

Zaman, Khalequ, Anne Schuind, Samuel Adjei, et al.. (2024). Safety and immunogenicity of Innovax bivalent human papillomavirus vaccine in girls 9–14 years of age: Interim analysis from a phase 3 clinical trial. Vaccine. 42(9). 2290–2298. 10 indexed citations

Bhat, Niranjan, Elisabeth Vodicka, Ashish Bavdekar, et al.. (2024). The evidence base for rotavirus vaccination in India: Current status, future needs. Vaccine. 44. 126551–126551. 2 indexed citations

Chaabane, Sonia, et al.. (2023). Pregnancy exposure registries for drugs and vaccines in low-income and middle-income countries: scoping review protocol. BMJ Open. 13(5). e070543–e070543.

Chokephaibulkit, Kulkanya, Thanyawee Puthanakit, Surasith Chaithongwongwatthana, et al.. (2023). Effective and safe transfer of maternal antibodies persisting two months postpartum following maternal immunization with different doses of recombinant pertussis-containing vaccines. Vaccine. 42(2). 383–395. 7 indexed citations

Puthanakit, Thanyawee, Kulkanya Chokephaibulkit, Surasith Chaithongwongwatthana, et al.. (2023). A phase 2 randomized controlled dose-ranging trial of recombinant pertussis booster vaccines containing genetically inactivated pertussis toxin in pregnant women. Vaccine. 41(31). 4541–4553. 7 indexed citations

10.

Hindiyeh, Musa, et al.. (2022). Introducing ROTAVAC® to the occupied Palestinian Territories: Impact on diarrhea incidence, rotavirus prevalence and genotype composition. Vaccine. 41(4). 945–954. 2 indexed citations

11.

Brunwasser, Steven M., Amanda J. Driscoll, Deshayne B. Fell, et al.. (2020). Assessing the strength of evidence for a causal effect of respiratory syncytial virus lower respiratory tract infections on subsequent wheezing illness: a systematic review and meta-analysis. The Lancet Respiratory Medicine. 8(8). 795–806. 65 indexed citations

12.

Domingo, Cristina, et al.. (2019). Long-term immunity against yellow fever in children vaccinated during infancy: a longitudinal cohort study. The Lancet Infectious Diseases. 19(12). 1363–1370. 41 indexed citations

13.

Newman, Laura P., Niranjan Bhat, Jessica A. Fleming, & Kathleen M. Neuzil. (2018). Global influenza seasonality to inform country-level vaccine programs: An analysis of WHO FluNet influenza surveillance data between 2011 and 2016. PLoS ONE. 13(2). e0193263–e0193263. 53 indexed citations

14.

Fleming, Jessica A., Elizabeth Rowley, Justin R. Ortiz, et al.. (2018). Implementation of maternal influenza immunization in El Salvador: Experiences and lessons learned from a mixed-methods study. Vaccine. 36(28). 4054–4061. 18 indexed citations

15.

Riddell, Corinne A., Niranjan Bhat, Louis Bont, et al.. (2018). Informing randomized clinical trials of respiratory syncytial virus vaccination during pregnancy to prevent recurrent childhood wheezing: A sample size analysis. Vaccine. 36(52). 8100–8109. 13 indexed citations

16.

Pathirana, Jayani, Flor M. Muñoz, Victoria Abbing‐Karahagopian, et al.. (2016). Neonatal death: Case definition & guidelines for data collection, analysis, and presentation of immunization safety data. Vaccine. 34(49). 6027–6037. 69 indexed citations

17.

Ferdinands, Jill M., Lauren E.W. Olsho, Anna A. Agan, et al.. (2014). Effectiveness of Influenza Vaccine Against Life-threatening RT-PCR-confirmed Influenza Illness in US Children, 2010–2012. The Journal of Infectious Diseases. 210(5). 674–683. 92 indexed citations

18.

Driscoll, Amanda J., Niranjan Bhat, Ruth A. Karron, Katherine L. O’Brien, & David R. Murdoch. (2012). Disk Diffusion Bioassays for the Detection of Antibiotic Activity in Body Fluids: Applications for the Pneumonia Etiology Research for Child Health Project. Clinical Infectious Diseases. 54(suppl_2). S159–S164. 67 indexed citations

19.

Guarner, Jeannette, Christopher D. Paddock, Wun‐Ju Shieh, et al.. (2006). Histopathologic and Immunohistochemical Features of Fatal Influenza Virus Infection in Children during the 2003–2004 Season. Clinical Infectious Diseases. 43(2). 132–140. 90 indexed citations

20.

Bhat, Niranjan, James Gaensbauer, Alan G. Fraser, et al.. (1997). Country-specific constancy by age incagA+ proportion ofHelicobacter pylori infections. International Journal of Cancer. 72(3). 453–456. 89 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact